Comas-Calonge A, Figueiredo R, Gay-Escoda C. Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review. J Clin Exp Dent. 2017;9(2):e302-7.

 

 

doi:10.4317/jced.53504

http://dx.doi.org/doi:10.4317/jced.53504

 

References

1. Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, et al. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.OralSurg Oral Med Oral Pathol Oral RadiolEndod. 2011;111:153-63.
https://doi.org/10.1016/j.tripleo.2010.04.015
PMid:20674411

 

2. Bagan JV, Hens-Aumente E, Leopoldo-Rodado M, Poveda-Roda R, Bagan L. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases. Oral Oncol. 2012;48:753-7.
https://doi.org/10.1016/j.oraloncology.2012.02.009
PMid:22401869

 

3. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws -2009 Update. J Oral Maxillofac Surg. 2009;67:2-12.
https://doi.org/10.1016/j.joms.2009.01.009
PMid:19371809

 

4. Hoefert S, Eufinger H. Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011;69:362-80.
https://doi.org/10.1016/j.joms.2010.06.200
PMid:21122968

 

5. Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, et al. Factors influencing surgical treatment of bisphosphonate related osteonecrosis of the jaws. Head Neck. 2012;34:194-200.
https://doi.org/10.1002/hed.21708
PMid:21400630

 

6. Urrútia G, Confill X. Prisma declaration: A proposal to improve the publication of systematic reviews and meta-analysis. Med Clin (Barc). 2010;135:507-11. 
https://doi.org/10.1016/j.medcli.2010.01.015
PMid:20206945

 

7. Stanton DC, Balasanian E. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg. 2009;67:943-50.
https://doi.org/10.1016/j.joms.2008.12.057
PMid:19375001

 

8. Voss PJ, JoshiOshero J, Kovalova-Müller A, Veigel Merino EA, Sauerbier S, Al-Jamali J, et al. Surgicaltreatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and followup of 21 patients. J Craniomaxillofac Surg. 2012;40:719-25.
https://doi.org/10.1016/j.jcms.2012.01.005
PMid:22336489

 

9. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30:390-5.
https://doi.org/10.1016/j.amjoto.2008.07.014
PMid:19880027

 

10. Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, et al. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol. 2011;47:420-4.
https://doi.org/10.1016/j.oraloncology.2011.02.024
PMid:21439892

 

11. Mücke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, et al. Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res ClinOncol. 2011;137:907-13.
https://doi.org/10.1007/s00432-010-0953-1
PMid:20927569

 

12. Martins MA, Martins MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol. 2012;48:79-84.
https://doi.org/10.1016/j.oraloncology.2011.08.010
PMid:21940198

 

13. Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol. 2012;48:469-74.
https://doi.org/10.1016/j.oraloncology.2011.12.004
PMid:22265335

 

14. Ferlito S, Puzzo S, Palermo F, Verzì P. Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg. 2012;50:425-9.
https://doi.org/10.1016/j.bjoms.2011.08.004
PMid:21907470

 

15. Freiberger JJ, Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE, et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg. 2007;65:1321-7.
https://doi.org/10.1016/j.joms.2007.03.019
PMid:17577496

 

16. Freiberger JJ. Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:96-106.
https://doi.org/10.1016/j.joms.2008.12.003
PMid:19371820

 

17. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw -2014 Update. J Oral Maxillofac Surg. 2014;72:1938-56.
https://doi.org/10.1016/j.joms.2014.04.031
PMid:25234529

 

18. Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, et al. Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg. 2012;70:2501-7.
https://doi.org/10.1016/j.joms.2012.05.019
PMid:22883322

 

19. Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:85-95.
https://doi.org/10.1016/j.joms.2009.01.006
PMid:19371819

 

20. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, et al. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg. 2011;69:84-91.
https://doi.org/10.1016/j.joms.2010.07.014
PMid:20971542

 

21. Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, et al. Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer. 2010;18:449-60.
https://doi.org/10.1007/s00520-009-0688-1
PMid:19609572

 

22. Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca JP, et al. Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med Sci. 2010; 25:101-13.
https://doi.org/10.1007/s10103-009-0687-y
PMid:19543768

 

23. Curi MM, Cossolin GS, Koga DH, Zardetto C, Christianini S, Feher O, et al. Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg. 2011;69:2465-72.
https://doi.org/10.1016/j.joms.2011.02.078
PMid:21763050

 

24. Moretti F, Pelliccioni GA, Montebugnoli L, Marchetti C. A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.OralSurg Oral Med Oral Pathol Oral RadiolEndod. 2011;112:777-82.
https://doi.org/10.1016/j.tripleo.2011.07.004
PMid:22000426

 

25. Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, et al. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2011;112:195-202.
https://doi.org/10.1016/j.tripleo.2011.02.037
PMid:21622014

 

26. Fortuna G, Ruoppo E, Pollio A, Aria M, Adamo D, Leuci S, et al. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome. J Oral Pathol Med. 2012;41:222-8.
https://doi.org/10.1111/j.1600-0714.2011.01095.x
PMid:22092390

 

27. Lerman MA, Xie W, Treister NS, Richardson PG, Weller EA, Woo SB. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes. Oral Oncol. 2013;49:977-83.
https://doi.org/10.1016/j.oraloncology.2013.05.012
PMid:23830962

 

28. Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2007;104:473-7.
https://doi.org/10.1016/j.tripleo.2007.01.008
PMid:17482847

 

29. Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, et al.A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 2014;50:1049-57.
https://doi.org/10.1016/j.oraloncology.2014.08.016
PMid:25240948